Class information for:
Level 3: MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
482 23544 33.7 73%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
482 3       MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN 23544
713 2             MULTIPLE MYELOMA//MYELOMA//LENALIDOMIDE 12863
967 2             AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS 10681

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 MULTIPLE MYELOMA authKW 2243097 15% 49% 3524
2 AMYLOIDOSIS authKW 1147237 6% 61% 1454
3 TRANSTHYRETIN authKW 653705 3% 68% 740
4 MYELOMA authKW 507071 4% 47% 837
5 AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS journal 475974 2% 68% 537
6 BORTEZOMIB authKW 267450 2% 35% 586
7 AL AMYLOIDOSIS authKW 266070 1% 92% 223
8 PLASMACYTOMA authKW 263305 1% 63% 325
9 LENALIDOMIDE authKW 262809 2% 50% 410
10 AMYLOID authKW 218972 4% 18% 928

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 120023 22% 2% 5220
2 Oncology 23466 18% 1% 4223
3 Pathology 11688 7% 1% 1629
4 Medicine, General & Internal 9688 11% 0% 2555
5 Medical Laboratory Technology 8553 3% 1% 801
6 Transplantation 5112 3% 1% 812
7 Medicine, Research & Experimental 3686 6% 0% 1371
8 Urology & Nephrology 2749 4% 0% 919
9 Biochemistry & Molecular Biology 2523 13% 0% 3108
10 Immunology 1838 6% 0% 1445

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 AMYLOIDOSIS 141771 1% 70% 157
2 MYELOMA THER Y 131539 1% 52% 194
3 HEMATOL 123360 9% 5% 2187
4 AMYLOID TREATMENT PROGRAM 106410 0% 96% 86
5 MYELOMA UNIT 85740 0% 73% 91
6 AMYLOIDOSIS TREATMENT 82531 0% 83% 77
7 JEROME LIPPER MULTIPLE MYELOMA 74083 1% 45% 126
8 BING WALDENSTROMS MACROGLOBULINEMIA 51797 0% 78% 51
9 HUMAN IMMUNOL CANC PROGRAM 41598 0% 71% 45
10 HEMATOL INTERNAL MED 40106 1% 24% 130

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS 475974 2% 68% 537
2 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 54250 1% 24% 179
3 CLINICAL LYMPHOMA & MYELOMA 36049 0% 29% 95
4 BRITISH JOURNAL OF HAEMATOLOGY 35596 3% 5% 616
5 EUROPEAN JOURNAL OF HAEMATOLOGY 27334 1% 8% 286
6 BLOOD 26910 4% 3% 864
7 LEUKEMIA & LYMPHOMA 23910 2% 5% 379
8 AMERICAN JOURNAL OF HEMATOLOGY 15924 1% 5% 274
9 AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION 13802 0% 67% 16
10 LEUKEMIA 13756 1% 4% 288

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 MULTIPLE MYELOMA 2243097 15% 49% 3524 Search MULTIPLE+MYELOMA Search MULTIPLE+MYELOMA
2 AMYLOIDOSIS 1147237 6% 61% 1454 Search AMYLOIDOSIS Search AMYLOIDOSIS
3 TRANSTHYRETIN 653705 3% 68% 740 Search TRANSTHYRETIN Search TRANSTHYRETIN
4 MYELOMA 507071 4% 47% 837 Search MYELOMA Search MYELOMA
5 BORTEZOMIB 267450 2% 35% 586 Search BORTEZOMIB Search BORTEZOMIB
6 AL AMYLOIDOSIS 266070 1% 92% 223 Search AL+AMYLOIDOSIS Search AL+AMYLOIDOSIS
7 PLASMACYTOMA 263305 1% 63% 325 Search PLASMACYTOMA Search PLASMACYTOMA
8 LENALIDOMIDE 262809 2% 50% 410 Search LENALIDOMIDE Search LENALIDOMIDE
9 AMYLOID 218972 4% 18% 928 Search AMYLOID Search AMYLOID
10 FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 193345 1% 89% 168 Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 BIRD, JM , OWEN, RG , D'SA, S , SNOWDEN, JA , PRATT, G , ASHCROFT, J , YONG, K , COOK, G , FEYLER, S , DAVIES, F , ET AL (2011) GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA 2011.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 154. ISSUE 1. P. 32 -75 196 88% 115
2 DISPENZIERI, A , BUADI, F , KUMAR, SK , REEDER, CB , SHER, T , LACY, MQ , KYLE, RA , MIKHAEL, JR , ROY, V , LEUNG, N , ET AL (2015) TREATMENT OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS: MAYO STRATIFICATION OF MYELOMA AND RISK-ADAPTED THERAPY (MSMART) CONSENSUS STATEMENT.MAYO CLINIC PROCEEDINGS. VOL. 90. ISSUE 8. P. 1054 -1081 168 98% 6
3 WECHALEKAR, AD , GILLMORE, JD , HAWKINS, PN , (2016) SYSTEMIC AMYLOIDOSIS.LANCET. VOL. 387. ISSUE 10038. P. 2641 -2654 118 93% 9
4 PALLADINI, G , MERLINI, G , (2013) SYSTEMIC AMYLOIDOSES: WHAT AN INTERNIST SHOULD KNOW.EUROPEAN JOURNAL OF INTERNAL MEDICINE. VOL. 24. ISSUE 8. P. 729-739 176 95% 8
5 DISPENZIERI, A , GERTZ, MA , BUADI, F , (2012) WHAT DO I NEED TO KNOW ABOUT IMMUNOGLOBULIN LIGHT CHAIN (AL) AMYLOIDOSIS?.BLOOD REVIEWS. VOL. 26. ISSUE 4. P. 137 -154 155 96% 38
6 RAJKUMAR, SV , KUMAR, S , (2016) MULTIPLE MYELOMA: DIAGNOSIS AND TREATMENT.MAYO CLINIC PROCEEDINGS. VOL. 91. ISSUE 1. P. 101 -119 98 89% 14
7 MUCHTAR, E , BUADI, FK , DISPENZIERI, A , GERTZ, MA , (2016) IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS: FROM BASICS TO NEW DEVELOPMENTS IN DIAGNOSIS, PROGNOSIS AND THERAPY.ACTA HAEMATOLOGICA. VOL. 135. ISSUE 3. P. 172 -190 139 96% 2
8 JOHNSON, SM , CONNELLY, S , FEARNS, C , POWERS, ET , KELLY, JW , (2012) THE TRANSTHYRETIN AMYLOIDOSES: FROM DELINEATING THE MOLECULAR MECHANISM OF AGGREGATION LINKED TO PATHOLOGY TO A REGULATORY-AGENCY-APPROVED DRUG.JOURNAL OF MOLECULAR BIOLOGY. VOL. 421. ISSUE 2-3. P. 185-203 132 85% 94
9 PALUMBO, A , ANDERSON, K , (2011) MEDICAL PROGRESS MULTIPLE MYELOMA.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 364. ISSUE 11. P. 1046 -1060 72 90% 624
10 DISPENZIERI, A , RAJKUMAR, SV , GERTZ, MA , FONSECA, R , LACY, MQ , BERGSAGEL, PL , KYLE, RA , GREIPP, PR , WITZIG, TE , REEDER, CB , ET AL (2007) TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA BASED ON MAYO STRATIFICATION OF MYELOMA AND RISK-ADAPTED THERAPY (MSMART): CONSENSUS STATEMENT.MAYO CLINIC PROCEEDINGS. VOL. 82. ISSUE 3. P. 323-341 156 97% 75

Classes with closest relation at Level 3


Rank Class id link
1 422 C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN
2 118 EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE
3 653 PRION//PRION PROTEIN//CREUTZFELDT JAKOB DISEASE
4 49 ALZHEIMERS DISEASE//AMYOTROPHIC LATERAL SCLEROSIS//DEMENTIA
5 51 HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD
6 219 PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS//PROTEIN FOLDING//PROTEIN STRUCTURE PREDICTION
7 371 PERITONEAL DIALYSIS INTERNATIONAL//UROLOGY & NEPHROLOGY//PERITONEAL DIALYSIS
8 336 DERMATOLOGY//BEHCETS DISEASE//DERMATOL
9 204 PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE
10 534 PYRIMIDINOPHANES//SOLID PHASE SYNTHESIS//INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH

Go to start page